EC Number |
Inhibitors |
Structure |
---|
3.1.4.17 | 1-(2-methylbenzyl)-7-(2-oxopropyl)-3-propyl-3,7-dihydro-1H-purine-2,6-dione |
- |
|
3.1.4.17 | 1-(3-chlorobenzyl)-3-propyl-3,7-dihydro-1H-purine-2,6-dione |
- |
|
3.1.4.17 | 1-(3-chlorobenzyl)-7-(2-oxopropyl)-3-propyl-3,7-dihydro-1H-purine-2,6-dione |
- |
|
3.1.4.17 | 1-(3-methylbenzyl)-3-propyl-3,7-dihydro-1H-purine-2,6-dione |
- |
|
3.1.4.17 | 1-(4-chlorobenzyl)-3-propyl-3,7-dihydro-1H-purine-2,6-dione |
- |
|
3.1.4.17 | 1-(4-chlorobenzyl)-7-(2-oxopropyl)-3-propyl-3,7-dihydro-1H-purine-2,6-dione |
- |
|
3.1.4.17 | 1-(4-methylbenzyl)-3-propyl-3,7-dihydro-1H-purine-2,6-dione |
- |
|
3.1.4.17 | 1-(4-methylbenzyl)-7-(2-oxopropyl)-3-propyl-3,7-dihydro-1H-purine-2,6-dione |
- |
|
3.1.4.17 | 1-benzyl-7-(2-oxopropyl)-3-propyl-3,7-dihydro-1H-purine-2,6-dione |
- |
|
3.1.4.17 | 2-cyclohexyl-2-methyl-N1-[3-(2-oxo-1,2-dihydro-6-quinolyl,oxy)propyl]-1-hydrazinecarboxamide |
IC50: 0.00000034 mM, PDE3A, highly selective PDE3 inhibitor; IC50: 0.0000019 mM, PDE3B; IC50: 0.0.0209 mM, PDE2; IC50: 0.1129 mM, PDE1 |
|